CD74-NRG1 fusions in lung adenocarcinoma
- PMID: 24469108
- DOI: "V体育ios版" 10.1158/2159-8290.CD-13-0633
CD74-NRG1 fusions in lung adenocarcinoma
Abstract (V体育平台登录)
We discovered a novel somatic gene fusion, CD74-NRG1, by transcriptome sequencing of 25 lung adenocarcinomas of never smokers. By screening 102 lung adenocarcinomas negative for known oncogenic alterations, we found four additional fusion-positive tumors, all of which were of the invasive mucinous subtype. Mechanistically, CD74-NRG1 leads to extracellular expression of the EGF-like domain of NRG1 III-β3, thereby providing the ligand for ERBB2-ERBB3 receptor complexes. Accordingly, ERBB2 and ERBB3 expression was high in the index case, and expression of phospho-ERBB3 was specifically found in tumors bearing the fusion (P < 0. 0001). Ectopic expression of CD74-NRG1 in lung cancer cell lines expressing ERBB2 and ERBB3 activated ERBB3 and the PI3K-AKT pathway, and led to increased colony formation in soft agar VSports手机版. Thus, CD74-NRG1 gene fusions are activating genomic alterations in invasive mucinous adenocarcinomas and may offer a therapeutic opportunity for a lung tumor subtype with, so far, no effective treatment. .
Significance: CD74–NRG1 fusions may represent a therapeutic opportunity for invasive mucinous lung adenocarcinomas, a tumor with no effective treatment that frequently presents with multifocal unresectable disease. V体育安卓版.
V体育安卓版 - Publication types
MeSH terms
- "V体育平台登录" Actions
- Actions (V体育平台登录)
- "VSports手机版" Actions
- "V体育2025版" Actions
- VSports注册入口 - Actions
- Actions (V体育官网入口)
- "VSports app下载" Actions
- "V体育平台登录" Actions
- Actions (VSports手机版)
- Actions (V体育ios版)
- "VSports手机版" Actions
- Actions (VSports app下载)
- V体育2025版 - Actions
Substances
- V体育平台登录 - Actions
- Actions (V体育ios版)
- "V体育官网" Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
"V体育2025版" Research Materials
Miscellaneous
